Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL vs DP for Gametocyte Clearance in Zambian Children
NCT04009343Phase 3Active, not recruiting
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Jun 2019
- Primary completion
- Aug 2020
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in Malaria, sponsored by Johns Hopkins Bloomberg School of Public Health. Started Jun 2019; status: active, not recruiting.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT04009343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04009343.